Ranbaxy Laboratories has posted a net profit of Rs 89.1 crore for the quarter ended September 30, 2001, representing a 68 per cent growth over Rs 53.1 crore for the corresponding period last year.
Its sales of Rs 538.3 crore during the quarter witnessed a 16 per cent growth over Rs 464.1 crore for the quarter ended September 30, 2000.
The profit before tax (PBT) for the quarter includes a profit of Rs 72.7 crore arising from the sale of the company